Discussion
Adults with pulmonary arterial hypertension (PAH) taking Remodulin (treprostinil) or Veletri (epoprostenol) safely switched to Uptravi (selexipag) during carefully monitored hospital stays using a rapid dose-titration plan, a new study reports. The findings may help guide clinicians who are transitioning appropriate PAH patients from infusion therapy…